In the last 12 months, insiders at BECTON DICKINSON & CO ($BDX) filed 305 transactions with the SEC: 2 open-market purchases totaling $1,356,173 and 47 sales totaling $10,076,703. Net insider sentiment: net selling.
BECTON DICKINSON & CO operates in the Surgical & medical instruments & apparatus industry (Industrial Applications and Services sector).
Most Active Insiders
- Goette Roland (EVP and President, EMEA) — 18 transactions totaling $6,641,469
- Goette Roland (EVP and President EMEA) — 13 transactions totaling $3,204,678
- Garrison Michael David (EVP & President, Medical) — 12 transactions totaling $2,955,395
- Hickey David (EVP & President, Life Sciences) — 7 transactions totaling $1,856,946
- Byrd Richard (EVP & President Interventional) — 19 transactions totaling $1,535,284
View all SEC Filings for BECTON DICKINSON & CO (BDX).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| March 26, 2026 | Feld Michael | EVP, Chief Revenue Officer | S | Common Stock | 75 | $156.83 | 21,233.0000 | 285,845,000 | 0.35% | 0.00% |
| March 16, 2026 | Minnix Lanesha | EVP and General Counsel | A | Common Stock | 7492 | $0.00 | 7,492.0000 | 285,845,000 | 9999.99% | 0.00% |
| March 2, 2026 | Spikner Pamela L. | SVP Controller & CAO | A | Common Stock | 931 | $0.00 | 3,323.0000 | 285,845,000 | 38.92% | 0.00% |
| March 2, 2026 | Roque Vitor | Interim CFO | A | Common Stock | 931 | $0.00 | 6,510.0000 | 285,845,000 | 16.69% | 0.00% |
| Feb. 26, 2026 | Feld Michael | EVP, Chief Revenue Officer | S | Common Stock | 75 | $181.84 | 21,308.0000 | 285,845,000 | 0.35% | 0.00% |
| Feb. 18, 2026 | SCOTT BERTRAM L | Director | S | Common Stock | 953 | $182.61 | 36,763.0000 | 285,845,000 | 2.53% | 0.00% |
| Feb. 9, 2026 | BECTON DICKINSON & CO | Not found | J | Common Stock, par value $0.01 per share | 284771350 | $0.00 | 0.0000 | 285,845,000 | 100.00% | 99.62% |
| Feb. 4, 2026 | Huffines Robert Luther | Director | A | Rights to Common Stock Under BD Deferred Compensation Plan | 100 | $201.91 | 100.0000 | 285,845,000 | 9999.99% | 0.00% |
| Feb. 4, 2026 | Byington Carrie L | Director | A | Rights to Common Stock Under BD Deferred Compensation Plan | 30 | $201.91 | 1,714.0000 | 285,845,000 | 1.78% | 0.00% |
| Feb. 4, 2026 | Jones Christopher Ian Montague | Director | A | Rights to Common Stock Under BD Deferred Compensation Plan | 272 | $201.91 | 11,649.0000 | 285,845,000 | 2.39% | 0.00% |
| Jan. 27, 2026 | RING TIMOTHY M | Director | A | Common Stock | 1098 | $0.00 | 61,445.0000 | 285,845,000 | 1.82% | 0.00% |
| Jan. 27, 2026 | Wright Jacqueline | Director | A | Common Stock | 1098 | $0.00 | 1,279.0000 | 285,845,000 | 606.63% | 0.00% |
| Jan. 27, 2026 | Henderson Jeffrey William | Director | A | Common Stock | 1098 | $0.00 | 9,158.0000 | 285,845,000 | 13.62% | 0.00% |
| Jan. 27, 2026 | ECKERT R ANDREW | Director | A | Common Stock | 1098 | $0.00 | 10,423.0000 | 285,845,000 | 11.77% | 0.00% |
| Jan. 27, 2026 | Byington Carrie L | Director | A | Common Stock | 1098 | $0.00 | 5,018.0000 | 285,845,000 | 28.01% | 0.00% |
| Jan. 27, 2026 | Jones Christopher Ian Montague | Director | A | Common Stock | 1098 | $0.00 | 24,304.0000 | 285,845,000 | 4.73% | 0.00% |
| Jan. 27, 2026 | HAYES GREGORY | Director | A | Common Stock | 1098 | $0.00 | 7,159.0000 | 285,845,000 | 18.12% | 0.00% |
| Jan. 27, 2026 | Brown William M | Director | A | Common Stock | 1098 | $0.00 | 4,663.0000 | 285,845,000 | 30.80% | 0.00% |
| Jan. 27, 2026 | Huffines Robert Luther | Director | A | Common Stock | 1098 | $0.00 | 1,279.0000 | 285,845,000 | 606.63% | 0.00% |
| Jan. 27, 2026 | SCOTT BERTRAM L | Director | A | Common Stock | 1098 | $0.00 | 37,716.0000 | 285,845,000 | 3.00% | 0.00% |
| Jan. 27, 2026 | Waldstreicher Joanne | Director | A | Common Stock | 1098 | $0.00 | 3,391.0000 | 285,845,000 | 47.88% | 0.00% |
| Jan. 26, 2026 | Feld Michael | EVP, CRO & Pres. Life Sciences | S | Common Stock | 75 | $202.73 | 16,431.0000 | 285,845,000 | 0.45% | 0.00% |
| Jan. 21, 2026 | Spikner Pamela L. | SVP Controller & CAO | F | Common Stock | 84 | $0.00 | 1,832.0000 | 285,845,000 | 4.38% | 0.00% |
| Jan. 15, 2026 | Garrison Michael David | EVP & Pres Med.Essntl&BioPharm | M | Stock Appreciation Rights | 3054 | $0.00 | 0.0000 | 285,845,000 | 100.00% | 0.00% |
| Jan. 15, 2026 | Garrison Michael David | EVP & Pres Med.Essntl&BioPharm | S | Common Stock | 600 | $209.00 | 13,105.0000 | 285,845,000 | 4.38% | 0.00% |
| Jan. 15, 2026 | Garrison Michael David | EVP & Pres Med.Essntl&BioPharm | M | Common Stock | 3054 | $167.91 | 16,159.0000 | 285,845,000 | 23.30% | 0.00% |
| Jan. 15, 2026 | Garrison Michael David | EVP & Pres Med.Essntl&BioPharm | D | Common Stock | 2454 | $209.00 | 13,705.0000 | 285,845,000 | 15.19% | 0.00% |
| Jan. 15, 2026 | Garrison Michael David | EVP & Pres Med.Essntl&BioPharm | S | Common Stock | 1010 | $206.54 | 12,095.0000 | 285,845,000 | 7.71% | 0.00% |
| Jan. 3, 2026 | Shan David | EVP and Chief ISC Officer | F | Common Stock | 44 | $0.00 | 8,926.0000 | 285,845,000 | 0.49% | 0.00% |
| Dec. 26, 2025 | Feld Michael | EVP, CRO & Pres. Life Sciences | S | Common Stock | 74 | $196.08 | 16,506.0000 | 288,509,000 | 0.45% | 0.00% |
| Dec. 17, 2025 | Garrison Michael David | EVP & Pres Med.Essntl&BioPharm | S | Common Stock | 629 | $196.03 | 13,105.0000 | 288,509,000 | 4.58% | 0.00% |
| Dec. 1, 2025 | Feld Michael | EVP, CRO & Pres. Life Sciences | S | Common Stock | 75 | $193.36 | 16,580.0000 | 288,509,000 | 0.45% | 0.00% |
| Dec. 1, 2025 | Huffines Robert Luther | Director | A | Common Stock | 180 | $0.00 | 180.0000 | 288,509,000 | 9999.99% | 0.00% |
| Dec. 1, 2025 | Wright Jacqueline | Director | A | Common Stock | 180 | $0.00 | 180.0000 | 288,509,000 | 9999.99% | 0.00% |
| Nov. 26, 2025 | Garrison Michael David | EVP & Pres Med.Essntl&BioPharm | A | Common Stock | 3048 | $0.00 | 15,503.0000 | 288,509,000 | 24.47% | 0.00% |
| Nov. 26, 2025 | Polen Thomas E Jr | Chairman, CEO and President | A | Common Stock | 22521 | $0.00 | 122,892.0000 | 288,509,000 | 22.44% | 0.01% |
| Nov. 26, 2025 | Polen Thomas E Jr | Chairman, CEO and President | F | Common Stock | 17421 | $0.00 | 105,471.0000 | 288,509,000 | 14.18% | 0.01% |
| Nov. 26, 2025 | Polen Thomas E Jr | Chairman, CEO and President | A | Stock Appreciation Rights | 165581 | $0.00 | 165,581.0000 | 288,509,000 | 9999.99% | 0.06% |
| Nov. 26, 2025 | Spikner Pamela L. | SVPController & Chief Acct Off | A | Common Stock | 1234 | $0.00 | 1,916.0000 | 288,509,000 | 180.94% | 0.00% |
| Nov. 26, 2025 | Goette Roland | EVP and President, EMEA | A | Common Stock | 1906 | $0.00 | 17,682.0000 | 288,509,000 | 12.08% | 0.00% |
| Nov. 26, 2025 | Goette Roland | EVP and President, EMEA | A | Common Stock | 1237 | $0.00 | 18,919.0000 | 288,509,000 | 7.00% | 0.00% |
| Nov. 26, 2025 | Goette Roland | EVP and President, EMEA | F | Common Stock | 138 | $0.00 | 18,781.0000 | 288,509,000 | 0.73% | 0.00% |
| Nov. 26, 2025 | Garrison Michael David | EVP & Pres Med.Essntl&BioPharm | A | Common Stock | 7568 | $0.00 | 12,455.0000 | 288,509,000 | 154.86% | 0.00% |
| Nov. 26, 2025 | Garrison Michael David | EVP & Pres Med.Essntl&BioPharm | F | Common Stock | 1769 | $0.00 | 13,734.0000 | 288,509,000 | 11.41% | 0.00% |
| Nov. 26, 2025 | Feld Michael | EVP, CRO & Pres. Life Sciences | A | Common Stock | 8829 | $0.00 | 17,074.0000 | 288,509,000 | 107.08% | 0.00% |
| Nov. 26, 2025 | Feld Michael | EVP, CRO & Pres. Life Sciences | F | Common Stock | 419 | $0.00 | 16,655.0000 | 288,509,000 | 2.45% | 0.00% |
| Nov. 26, 2025 | DelOrefice Christopher | EVP & Chief Financial Officer | A | Common Stock | 6006 | $0.00 | 27,227.0000 | 288,509,000 | 28.30% | 0.00% |
| Nov. 26, 2025 | DelOrefice Christopher | EVP & Chief Financial Officer | F | Common Stock | 4245 | $0.00 | 22,982.0000 | 288,509,000 | 15.59% | 0.00% |
| Nov. 26, 2025 | Byrd Richard | EVP & President Interventional | A | Common Stock | 6447 | $0.00 | 13,183.0000 | 288,509,000 | 95.71% | 0.00% |
| Nov. 26, 2025 | Byrd Richard | EVP & President Interventional | A | Common Stock | 2385 | $0.00 | 15,568.0000 | 288,509,000 | 18.09% | 0.00% |
| Nov. 26, 2025 | Byrd Richard | EVP & President Interventional | F | Common Stock | 1719 | $0.00 | 13,849.0000 | 288,509,000 | 11.04% | 0.00% |
| Nov. 26, 2025 | Muhsin Bilal | EVP & President Connected Care | A | Common Stock | 9530 | $0.00 | 21,751.0000 | 288,509,000 | 77.98% | 0.00% |
| Nov. 26, 2025 | Mocherla Pavan Kumar | EVP & President, Greater Asia | A | Common Stock | 2208 | $0.00 | 5,055.0000 | 288,509,000 | 77.56% | 0.00% |
| Nov. 26, 2025 | Mocherla Pavan Kumar | EVP & President, Greater Asia | A | Common Stock | 708 | $0.00 | 5,763.0000 | 288,509,000 | 14.01% | 0.00% |
| Nov. 26, 2025 | Shan David | EVP and Chief ISC Officer | A | Common Stock | 3504 | $0.00 | 8,079.0000 | 288,509,000 | 76.59% | 0.00% |
| Nov. 26, 2025 | Shan David | EVP and Chief ISC Officer | A | Common Stock | 1025 | $0.00 | 9,104.0000 | 288,509,000 | 12.69% | 0.00% |
| Nov. 26, 2025 | Shan David | EVP and Chief ISC Officer | F | Common Stock | 134 | $0.00 | 8,970.0000 | 288,509,000 | 1.47% | 0.00% |
| Nov. 26, 2025 | Neal Shana Carol | EVP and Chief People Officer | A | Common Stock | 6727 | $0.00 | 20,255.0000 | 288,509,000 | 49.73% | 0.00% |
| Nov. 26, 2025 | Neal Shana Carol | EVP and Chief People Officer | A | Common Stock | 3525 | $0.00 | 23,780.0000 | 288,509,000 | 17.40% | 0.00% |
| Nov. 26, 2025 | Neal Shana Carol | EVP and Chief People Officer | F | Common Stock | 2454 | $0.00 | 21,326.0000 | 288,509,000 | 10.32% | 0.00% |
| Nov. 7, 2025 | SCOTT BERTRAM L | Director | S | Common Stock | 217 | $176.58 | 35,816.0000 | 288,509,000 | 0.60% | 0.00% |
| Nov. 4, 2025 | Byington Carrie L | Director | A | Rights to Common Stock Under BD Deferred Compensation Plan | 34 | $178.71 | 1,675.0000 | 288,509,000 | 2.07% | 0.00% |
| Nov. 4, 2025 | Jones Christopher Ian Montague | Director | A | Rights to Common Stock Under BD Deferred Compensation Plan | 168 | $178.71 | 11,316.0000 | 288,509,000 | 1.51% | 0.00% |
| Oct. 27, 2025 | Feld Michael | EVP & President, Life Sciences | S | Common Stock | 57 | $186.01 | 8,245.0000 | 288,509,000 | 0.69% | 0.00% |
| Sept. 26, 2025 | Feld Michael | EVP & President, Life Sciences | S | Common Stock | 58 | $181.03 | 8,302.0000 | 288,693,000 | 0.69% | 0.00% |
| Sept. 10, 2025 | Fraser Claire | Director | S | Common Stock | 917 | $187.50 | 22,226.0000 | 288,693,000 | 3.96% | 0.00% |
| Sept. 1, 2025 | DelOrefice Christopher | EVP & Chief Financial Officer | F | Common Stock | 278 | $0.00 | 21,221.0000 | 288,693,000 | 1.29% | 0.00% |
| Sept. 1, 2025 | Byrd Richard | EVP & President Interventional | F | Common Stock | 216 | $0.00 | 6,736.0000 | 288,693,000 | 3.11% | 0.00% |
| Aug. 22, 2025 | Feld Michael | EVP & President, Life Sciences | S | Common Stock | 57 | $197.99 | 8,360.0000 | 288,693,000 | 0.68% | 0.00% |
| Aug. 20, 2025 | Feld Michael | EVP & President, Life Sciences | F | Common Stock | 773 | $0.00 | 8,417.0000 | 288,693,000 | 8.41% | 0.00% |
| Aug. 11, 2025 | HAYES GREGORY | Director | P | Common Stock | 5250 | $191.57 | 6,046.0000 | 288,693,000 | 659.55% | 0.00% |
| Aug. 8, 2025 | Fraser Claire | Director | S | Common Stock | 863 | $192.30 | 23,143.0000 | 288,693,000 | 3.59% | 0.00% |
| Aug. 7, 2025 | Jones Christopher Ian Montague | Director | A | Rights to Common Stock Under BD Deferred Compensation Plan | 168 | $178.25 | 11,089.0000 | 288,693,000 | 1.54% | 0.00% |
| Aug. 7, 2025 | Byington Carrie L | Director | A | Rights to Common Stock Under BD Deferred Compensation Plan | 34 | $178.25 | 1,632.0000 | 288,693,000 | 2.13% | 0.00% |
| July 18, 2025 | Garrison Michael David | EVP & President, Medical | S | Common Stock | 1 | $181.50 | 4,887.0000 | 288,693,000 | 0.02% | 0.00% |
| July 18, 2025 | Garrison Michael David | EVP & President, Medical | M | Stock Appreciation Rights | 6360 | $0.00 | 0.0000 | 288,693,000 | 100.00% | 0.00% |
| July 18, 2025 | Garrison Michael David | EVP & President, Medical | S | Common Stock | 1184 | $180.29 | 4,888.0000 | 288,693,000 | 19.50% | 0.00% |
| July 18, 2025 | Garrison Michael David | EVP & President, Medical | D | Common Stock | 5175 | $180.29 | 6,072.0000 | 288,693,000 | 46.01% | 0.00% |
| July 18, 2025 | Garrison Michael David | EVP & President, Medical | M | Common Stock | 6360 | $147.68 | 11,247.0000 | 288,693,000 | 130.14% | 0.00% |
| July 2, 2025 | Muhsin Bilal | EVP & President Connected Care | A | Common Stock | 12221 | $0.00 | 12,221.0000 | 288,693,000 | 9999.99% | 0.00% |
| June 2, 2025 | Shan David | EVP and Chief ISC Officer | S | Common Stock | 1166 | $171.19 | 4,575.0000 | 290,389,000 | 20.31% | 0.00% |
| May 6, 2025 | Byington Carrie L | Director | A | Rights to Common Stock Under BD Deferred Compensation Plan | 29 | $207.09 | 1,588.0000 | 290,389,000 | 1.86% | 0.00% |
| May 6, 2025 | Jones Christopher Ian Montague | Director | A | Rights to Common Stock Under BD Deferred Compensation Plan | 145 | $207.09 | 10,855.0000 | 290,389,000 | 1.35% | 0.00% |
| April 9, 2025 | Garrison Michael David | EVP & President, Medical | S | Common Stock | 479 | $197.28 | 4,887.0000 | 290,389,000 | 8.93% | 0.00% |
| April 4, 2025 | Neal Shana Carol | EVP and Chief People Officer | F | Common Stock | 1886 | $0.00 | 13,528.0000 | 290,389,000 | 12.24% | 0.00% |
| March 26, 2025 | HAYES GREGORY | Director | A | Common Stock | 796 | $0.00 | 796.0000 | 290,389,000 | 9999.99% | 0.00% |
| March 18, 2025 | Byrd Richard | EVP & President Interventional | S | Common Stock | 459 | $230.00 | 6,952.0000 | 290,389,000 | 6.19% | 0.00% |
| March 12, 2025 | Byrd Richard | EVP & President Interventional | S | Common Stock | 1940 | $224.91 | 7,411.0000 | 290,389,000 | 20.75% | 0.00% |
| March 1, 2025 | Garrison Michael David | EVP & President Medical | F | Common Stock | 178 | $0.00 | 5,366.0000 | 290,389,000 | 3.21% | 0.00% |
| Feb. 12, 2025 | SCOTT BERTRAM L | Director | S | Common Stock | 700 | $227.99 | 36,033.0000 | 290,389,000 | 1.91% | 0.00% |
| Feb. 10, 2025 | Henderson Jeffrey William | Director | P | Common Stock | 1500 | $233.62 | 8,030.0000 | 290,389,000 | 22.97% | 0.00% |
| Feb. 6, 2025 | Byington Carrie L | Director | A | Rights to Common Stock Under BD Deferred Compensation Plan | 121 | $247.60 | 1,552.0000 | 290,389,000 | 8.46% | 0.00% |
| Feb. 6, 2025 | Jones Christopher Ian Montague | Director | A | Rights to Common Stock Under BD Deferred Compensation Plan | 222 | $247.60 | 10,662.0000 | 290,389,000 | 2.13% | 0.00% |
| Jan. 28, 2025 | BURZIK CATHERINE M | Director | A | Common Stock | 930 | $0.00 | 14,264.0000 | 290,389,000 | 6.97% | 0.00% |
| Jan. 28, 2025 | Byington Carrie L | Director | A | Common Stock | 930 | $0.00 | 3,834.0000 | 290,389,000 | 32.02% | 0.00% |
| Jan. 28, 2025 | Brown William M | Director | A | Common Stock | 930 | $0.00 | 3,486.0000 | 290,389,000 | 36.38% | 0.00% |
| Jan. 28, 2025 | SCOTT BERTRAM L | Director | A | Common Stock | 930 | $0.00 | 36,733.0000 | 290,389,000 | 2.60% | 0.00% |
| Jan. 28, 2025 | Waldstreicher Joanne | Director | A | Common Stock | 930 | $0.00 | 2,270.0000 | 290,389,000 | 69.40% | 0.00% |
| Jan. 28, 2025 | ECKERT R ANDREW | Director | A | Common Stock | 930 | $0.00 | 9,170.0000 | 290,389,000 | 11.29% | 0.00% |
| Jan. 28, 2025 | Fraser Claire | Director | A | Common Stock | 930 | $0.00 | 24,006.0000 | 290,389,000 | 4.03% | 0.00% |
| Jan. 28, 2025 | Henderson Jeffrey William | Director | A | Common Stock | 930 | $0.00 | 6,530.0000 | 290,389,000 | 16.61% | 0.00% |
| Jan. 28, 2025 | Jones Christopher Ian Montague | Director | A | Common Stock | 930 | $0.00 | 22,701.0000 | 290,389,000 | 4.27% | 0.00% |
| Jan. 28, 2025 | RING TIMOTHY M | Director | A | Common Stock | 930 | $0.00 | 60,151.0000 | 290,389,000 | 1.57% | 0.00% |
| Jan. 21, 2025 | Neal Shana Carol | EVP and Chief People Officer | S | Common Stock | 787 | $240.00 | 15,414.0000 | 290,389,000 | 4.86% | 0.00% |
| Jan. 21, 2025 | Shan David | EVP and Chief ISC Officer | S | Common Stock | 500 | $240.00 | 5,741.0000 | 290,389,000 | 8.01% | 0.00% |
| Jan. 17, 2025 | Garrison Michael David | EVP & President, Medical | S | Common Stock | 597 | $236.51 | 5,544.0000 | 290,389,000 | 9.72% | 0.00% |
| Nov. 18, 2022 | Neal Shana Carol | EVP and Chief People Officer | M | Common Stock | 110 | $0.00 | 16,862.0000 | 0 | 0.66% | 0.00% |
| Nov. 21, 2024 | Neal Shana Carol | EVP and Chief People Officer | M | Rights to Common Stock Under Deferred Compensation Plan | 111 | $0.00 | 337.0000 | 291,009,000 | 24.78% | 0.00% |
| Nov. 20, 2023 | Neal Shana Carol | EVP and Chief People Officer | M | Rights to Common Stock Under Deferred Compensation Plan | 110 | $0.00 | 448.0000 | 288,392,000 | 19.71% | 0.00% |
| Nov. 18, 2022 | Neal Shana Carol | EVP and Chief People Officer | M | Rights to Common Stock Under BD Deferred Compensation Plan | 110 | $0.00 | 558.0000 | 0 | 16.47% | 0.00% |
| Jan. 7, 2025 | Neal Shana Carol | EVP and Chief People Officer | S | Common Stock | 788 | $235.00 | 16,201.0000 | 290,389,000 | 4.64% | 0.00% |
| Nov. 21, 2024 | Neal Shana Carol | EVP and Chief People Officer | F | Common Stock | 32 | $0.00 | 16,989.0000 | 291,009,000 | 0.19% | 0.00% |
| Nov. 21, 2024 | Neal Shana Carol | EVP and Chief People Officer | M | Common Stock | 111 | $0.00 | 17,021.0000 | 291,009,000 | 0.66% | 0.00% |
| Nov. 20, 2023 | Neal Shana Carol | EVP and Chief People Officer | F | Common Stock | 31 | $0.00 | 16,910.0000 | 288,392,000 | 0.18% | 0.00% |
| Nov. 20, 2023 | Neal Shana Carol | EVP and Chief People Officer | M | Common Stock | 110 | $0.00 | 16,941.0000 | 288,392,000 | 0.65% | 0.00% |
| Nov. 18, 2022 | Neal Shana Carol | EVP and Chief People Officer | F | Common Stock | 31 | $0.00 | 16,831.0000 | 0 | 0.18% | 0.00% |
| Jan. 3, 2025 | Shan David | EVP and Chief ISC Officer | F | Common Stock | 44 | $0.00 | 6,241.0000 | 290,389,000 | 0.70% | 0.00% |
| Dec. 19, 2024 | Garrison Michael David | EVP & President, Medical | S | Common Stock | 2838 | $223.33 | 6,141.0000 | 291,009,000 | 31.61% | 0.00% |
| Dec. 6, 2024 | Goette Roland | EVP and President, EMEA | M | Stock Appreciation Rights | 6339 | $0.00 | 0.0000 | 291,009,000 | 100.00% | 0.00% |
| Dec. 6, 2024 | Goette Roland | EVP and President, EMEA | M | Stock Appreciation Rights | 6995 | $0.00 | 0.0000 | 291,009,000 | 100.00% | 0.00% |
| Dec. 9, 2024 | Goette Roland | EVP and President, EMEA | S | Common Stock | 638 | $219.03 | 15,516.0000 | 291,009,000 | 3.95% | 0.00% |
| Dec. 6, 2024 | Neal Shana Carol | EVP and Chief People Officer | S | Common Stock | 1000 | $220.49 | 16,989.0000 | 291,009,000 | 5.56% | 0.00% |
| Dec. 6, 2024 | Goette Roland | EVP and President, EMEA | S | Common Stock | 4483 | $221.01 | 25,644.0000 | 291,009,000 | 14.88% | 0.00% |
| Dec. 6, 2024 | Goette Roland | EVP and President, EMEA | M | Common Stock | 6339 | $167.91 | 30,127.0000 | 291,009,000 | 26.65% | 0.00% |
| Dec. 6, 2024 | Goette Roland | EVP and President, EMEA | M | Common Stock | 6995 | $147.68 | 23,788.0000 | 291,009,000 | 41.65% | 0.00% |
| Dec. 6, 2024 | Goette Roland | EVP and President, EMEA | D | Common Stock | 9490 | $221.01 | 16,154.0000 | 291,009,000 | 37.01% | 0.00% |
| Dec. 5, 2024 | Shan David | EVP and Chief ISC Officer | S | Common Stock | 1500 | $220.25 | 6,285.0000 | 291,009,000 | 19.27% | 0.00% |
| Nov. 26, 2024 | Mocherla Pavan Kumar | EVP & President, Greater Asia | F | Common Stock | 25 | $0.00 | 2,847.0000 | 291,009,000 | 0.87% | 0.00% |
| Nov. 26, 2024 | Quinn Michelle | EVP and General Counsel | A | Rights to Common Stock Under Deferred Compensation Plan | 416 | $0.00 | 416.0000 | 291,009,000 | 9999.99% | 0.00% |
| Nov. 26, 2024 | Byrd Richard | EVP & President Interventional | F | Common Stock | 1204 | $0.00 | 9,351.0000 | 291,009,000 | 11.41% | 0.00% |
| Nov. 26, 2024 | Shan David | EVP and Chief ISC Officer | A | Common Stock | 1110 | $0.00 | 6,803.0000 | 291,009,000 | 19.50% | 0.00% |
| Nov. 26, 2024 | Shan David | EVP and Chief ISC Officer | A | Common Stock | 1106 | $0.00 | 7,909.0000 | 291,009,000 | 16.26% | 0.00% |
| Nov. 26, 2024 | Shan David | EVP and Chief ISC Officer | F | Common Stock | 124 | $0.00 | 7,785.0000 | 291,009,000 | 1.57% | 0.00% |
| Nov. 26, 2024 | Shan David | EVP and Chief ISC Officer | A | Stock Appreciation Rights | 4350 | $0.00 | 4,350.0000 | 291,009,000 | 9999.99% | 0.00% |
| Nov. 26, 2024 | Goette Roland | EVP and President, EMEA | F | Common Stock | 196 | $0.00 | 16,793.0000 | 291,009,000 | 1.15% | 0.00% |
| Nov. 26, 2024 | Goette Roland | EVP and President, EMEA | A | Common Stock | 2161 | $0.00 | 16,989.0000 | 291,009,000 | 14.57% | 0.00% |
| Nov. 26, 2024 | Goette Roland | EVP and President, EMEA | A | Common Stock | 944 | $0.00 | 14,828.0000 | 291,009,000 | 6.80% | 0.00% |
| Nov. 26, 2024 | Garrison Michael David | EVP & President, Medical | A | Stock Appreciation Rights | 10004 | $0.00 | 10,004.0000 | 291,009,000 | 9999.99% | 0.00% |
| Nov. 26, 2024 | Garrison Michael David | EVP & President, Medical | F | Common Stock | 1230 | $0.00 | 8,979.0000 | 291,009,000 | 12.05% | 0.00% |
| Nov. 26, 2024 | Garrison Michael David | EVP & President, Medical | A | Common Stock | 2275 | $0.00 | 10,209.0000 | 291,009,000 | 28.67% | 0.00% |
| Nov. 26, 2024 | Garrison Michael David | EVP & President, Medical | A | Common Stock | 2553 | $0.00 | 7,934.0000 | 291,009,000 | 47.44% | 0.00% |
| Nov. 26, 2024 | Feld Michael | EVP & President, Life Sciences | A | Stock Appreciated Rights | 10004 | $0.00 | 10,004.0000 | 291,009,000 | 9999.99% | 0.00% |
| Nov. 26, 2024 | Feld Michael | EVP & President, Life Sciences | A | Common Stock | 2553 | $0.00 | 9,190.0000 | 291,009,000 | 38.47% | 0.00% |
| Nov. 26, 2024 | Ezell Antoine C | EVP, President Americas & CMO | A | Stock Appreciation Rights | 5437 | $0.00 | 5,437.0000 | 291,009,000 | 9999.99% | 0.00% |
| Nov. 26, 2024 | Ezell Antoine C | EVP, President Americas & CMO | F | Common Stock | 1357 | $0.00 | 11,970.0000 | 291,009,000 | 10.18% | 0.00% |
| Nov. 26, 2024 | Ezell Antoine C | EVP, President Americas & CMO | A | Common Stock | 2619 | $0.00 | 13,327.0000 | 291,009,000 | 24.46% | 0.00% |
| Nov. 26, 2024 | Ezell Antoine C | EVP, President Americas & CMO | A | Common Stock | 1388 | $0.00 | 10,708.0000 | 291,009,000 | 14.89% | 0.00% |
| Nov. 26, 2024 | DelOrefice Christopher | EVP & Chief Financial Officer | A | Stock Appreciation Rights | 19138 | $0.00 | 19,138.0000 | 291,009,000 | 9999.99% | 0.01% |
| Nov. 26, 2024 | DelOrefice Christopher | EVP & Chief Financial Officer | F | Common Stock | 5192 | $0.00 | 21,499.0000 | 291,009,000 | 19.45% | 0.00% |
| Nov. 26, 2024 | DelOrefice Christopher | EVP & Chief Financial Officer | A | Common Stock | 9015 | $0.00 | 26,691.0000 | 291,009,000 | 51.00% | 0.00% |
| Nov. 26, 2024 | DelOrefice Christopher | EVP & Chief Financial Officer | A | Common Stock | 4884 | $0.00 | 17,676.0000 | 291,009,000 | 38.18% | 0.00% |
| Nov. 26, 2024 | Byrd Richard | EVP & President Interventional | A | Stock Appreciation Rights | 8699 | $0.00 | 8,699.0000 | 291,009,000 | 9999.99% | 0.00% |
| Nov. 26, 2024 | Goette Roland | EVP and President, EMEA | A | Stock Appreciation Rights | 3697 | $0.00 | 3,697.0000 | 291,009,000 | 9999.99% | 0.00% |
| Nov. 26, 2024 | Byrd Richard | EVP & President Interventional | A | Common Stock | 2275 | $0.00 | 10,555.0000 | 291,009,000 | 27.48% | 0.00% |
| Nov. 26, 2024 | Byrd Richard | EVP & President Interventional | A | Common Stock | 2220 | $0.00 | 8,280.0000 | 291,009,000 | 36.63% | 0.00% |
| Nov. 26, 2024 | Polen Thomas E Jr | Chairman, CEO and President | A | Stock Appreciation Rights | 60891 | $0.00 | 60,891.0000 | 291,009,000 | 9999.99% | 0.02% |
| Nov. 26, 2024 | Polen Thomas E Jr | Chairman, CEO and President | F | Common Stock | 23564 | $0.00 | 100,371.0000 | 291,009,000 | 19.01% | 0.01% |
| Nov. 26, 2024 | Polen Thomas E Jr | Chairman, CEO and President | A | Common Stock | 36585 | $0.00 | 123,935.0000 | 291,009,000 | 41.88% | 0.01% |
| Nov. 26, 2024 | Polen Thomas E Jr | Chairman, CEO and President | A | Common Stock | 15539 | $0.00 | 87,350.0000 | 291,009,000 | 21.64% | 0.01% |
| Nov. 26, 2024 | Neal Shana Carol | EVP and Chief People Officer | A | Stock Appreciation Rights | 8264 | $0.00 | 8,264.0000 | 291,009,000 | 9999.99% | 0.00% |
| Nov. 26, 2024 | Neal Shana Carol | EVP and Chief People Officer | F | Common Stock | 509 | $0.00 | 17,989.0000 | 291,009,000 | 2.75% | 0.00% |
| Nov. 26, 2024 | Quinn Michelle | EVP and General Counsel | A | Rights to Common Stock Under Deferred Compensation Plan | 416 | $0.00 | 7,984.0000 | 291,009,000 | 5.50% | 0.00% |
| Nov. 26, 2024 | Quinn Michelle | EVP and General Counsel | A | Stock Appreciation Rights | 7568 | $0.00 | 7,568.0000 | 291,009,000 | 9999.99% | 0.00% |
| Nov. 26, 2024 | Quinn Michelle | EVP and General Counsel | F | Common Stock | 376 | $0.00 | 6,927.0000 | 291,009,000 | 5.15% | 0.00% |
| Nov. 26, 2024 | Quinn Michelle | EVP and General Counsel | A | Common Stock | 416 | $0.00 | 7,303.0000 | 291,009,000 | 6.04% | 0.00% |
| Nov. 26, 2024 | Quinn Michelle | EVP and General Counsel | A | Common Stock | 1932 | $0.00 | 6,887.0000 | 291,009,000 | 38.99% | 0.00% |
| Nov. 26, 2024 | Mocherla Pavan Kumar | EVP & President Greater Asia | A | Stock Appreciation Rights | 3426 | $0.00 | 3,426.0000 | 291,009,000 | 9999.99% | 0.00% |
| Nov. 26, 2024 | Mocherla Pavan Kumar | EVP & President Greater Asia | F | Common Stock | 20 | $0.00 | 2,852.0000 | 291,009,000 | 0.70% | 0.00% |
| Nov. 26, 2024 | Mocherla Pavan Kumar | EVP & President Greater Asia | A | Common Stock | 180 | $0.00 | 2,872.0000 | 291,009,000 | 6.69% | 0.00% |
| Nov. 26, 2024 | Mocherla Pavan Kumar | EVP & President Greater Asia | A | Common Stock | 875 | $0.00 | 2,692.0000 | 291,009,000 | 48.16% | 0.00% |
| Nov. 26, 2024 | Neal Shana Carol | EVP and Chief People Officer | A | Common Stock | 2109 | $0.00 | 18,498.0000 | 291,009,000 | 12.87% | 0.00% |
| Nov. 5, 2024 | Jones Christopher Ian Montague | Director | A | Rights to Common Stock Under BD Deferred Compensation Plan | 128 | $233.59 | 10,392.0000 | 291,009,000 | 1.25% | 0.00% |
| Nov. 5, 2024 | Byington Carrie L | Director | A | Rights to Common Stock Under BD Deferred Compensation Plan | 128 | $233.59 | 1,424.0000 | 291,009,000 | 9.88% | 0.00% |
| Sept. 7, 2024 | DelOrefice Christopher | EVP & Chief Financial Officer | F | Common Stock | 466 | $0.00 | 12,792.0000 | 290,857,000 | 3.51% | 0.00% |
| Sept. 1, 2024 | DelOrefice Christopher | EVP & Chief Financial Officer | F | Common Stock | 254 | $0.00 | 13,258.0000 | 290,857,000 | 1.88% | 0.00% |
| Sept. 1, 2024 | Byrd Richard | EVP & President Interventional | F | Common Stock | 216 | $0.00 | 6,060.0000 | 290,857,000 | 3.44% | 0.00% |
| Aug. 20, 2024 | Feld Michael | EVP & President, Life Sciences | A | Common Stock | 6637 | $0.00 | 6,637.0000 | 290,857,000 | 9999.99% | 0.00% |
| Aug. 14, 2024 | Goette Roland | EVP and President EMEA | M | Common Stock | 5295 | $132.54 | 17,837.0000 | 290,857,000 | 42.22% | 0.00% |
| Aug. 14, 2024 | Goette Roland | EVP and President EMEA | M | Stock Appreciated Rights | 5295 | $0.00 | 0.0000 | 290,857,000 | 100.00% | 0.00% |
| Aug. 14, 2024 | Goette Roland | EVP and President EMEA | D | Common Stock | 4018 | $234.08 | 13,819.0000 | 290,857,000 | 22.53% | 0.00% |
| July 31, 2024 | Byington Carrie L | Director | A | Rights to Common Stock Under BD Deferred Compensation Plan | 124 | $241.05 | 1,291.0000 | 290,857,000 | 10.63% | 0.00% |
| July 31, 2024 | Jones Christopher Ian Montague | Director | A | Rights to Common Stock Under BD Deferred Compensation Plan | 124 | $241.05 | 10,224.0000 | 290,857,000 | 1.23% | 0.00% |
| Feb. 5, 2024 | Jones Christopher Ian Montague | Director | A | Rights to Common Stock UnderBD Deferred Compensation Plan | 230 | $238.80 | 9,891.0000 | 288,392,000 | 2.38% | 0.00% |
| July 1, 2024 | Spoerel Thomas J | SVPController & Chief Acct Off | F | Common Stock | 48 | $0.00 | 2,046.0000 | 290,857,000 | 2.29% | 0.00% |
| June 10, 2024 | Spoerel Thomas J | SVP,Controller&Chief Acct Off | S | Common Stock | 300 | $239.31 | 2,093.0000 | 288,392,000 | 12.54% | 0.00% |
| May 15, 2024 | Goette Roland | EVP and President EMEA | S | Common Stock | 800 | $235.29 | 14,993.0000 | 288,392,000 | 5.07% | 0.00% |
| May 15, 2024 | Goette Roland | EVP and President EMEA | S | Common Stock | 1100 | $237.46 | 12,493.0000 | 288,392,000 | 8.09% | 0.00% |
| May 15, 2024 | Goette Roland | EVP and President EMEA | S | Common Stock | 1400 | $236.99 | 13,593.0000 | 288,392,000 | 9.34% | 0.00% |
| May 13, 2024 | Goette Roland | EVP and President EMEA | S | Common Stock | 28 | $237.90 | 15,793.0000 | 288,392,000 | 0.18% | 0.00% |
| May 13, 2024 | Goette Roland | EVP and President EMEA | S | Common Stock | 1572 | $237.14 | 15,821.0000 | 288,392,000 | 9.04% | 0.00% |
| May 13, 2024 | Goette Roland | EVP and President EMEA | S | Common Stock | 1700 | $236.28 | 17,393.0000 | 288,392,000 | 8.90% | 0.00% |
| May 3, 2024 | Byington Carrie L | Director | A | Rights to Common Stock Under BD Deferred Compensation Plan | 129 | $233.44 | 1,162.0000 | 288,392,000 | 12.49% | 0.00% |
| May 3, 2024 | Jones Christopher Ian Montague | Director | A | Rights to Common Stock Under BD Deferred Compensation Plan | 129 | $233.44 | 9,954.0000 | 288,392,000 | 1.31% | 0.00% |
| April 30, 2024 | Garrison Michael David | EVP & President Medical | S | Common Stock | 1715 | $232.81 | 5,381.0000 | 288,392,000 | 24.17% | 0.00% |
| April 4, 2024 | Neal Shana Carol | EVP and Chief People Officer | F | Common Stock | 1921 | $0.00 | 16,389.0000 | 288,392,000 | 10.49% | 0.00% |
| March 14, 2024 | Spoerel Thomas J | SVP,Controller&Chief Acct Off | S | Common Stock | 282 | $238.29 | 2,393.0000 | 288,392,000 | 10.54% | 0.00% |
| March 1, 2024 | Spoerel Thomas J | SVP,Controller&Chief Acct Off | F | Common Stock | 36 | $0.00 | 2,675.0000 | 288,392,000 | 1.33% | 0.00% |
| March 1, 2024 | Ezell Antoine C | EVP, President NA & CMO | F | Common Stock | 282 | $0.00 | 9,320.0000 | 288,392,000 | 2.94% | 0.00% |
| March 1, 2024 | Garrison Michael David | EVP & President Medical | F | Common Stock | 178 | $0.00 | 7,096.0000 | 288,392,000 | 2.45% | 0.00% |
| Feb. 5, 2024 | Jones Christopher Ian Montague | Director | A | Rights to Common Stock Under BD Deferred Compensation Plan | 126 | $238.80 | 9,787.0000 | 288,392,000 | 1.30% | 0.00% |
| Feb. 5, 2024 | Byington Carrie L | Director | A | Rights to Common Stock Under BD Deferred Compensation Plan | 126 | $238.80 | 1,029.0000 | 288,392,000 | 13.95% | 0.00% |
| Jan. 22, 2019 | BURZIK CATHERINE M | Director | A | Common Stock | 923 | $0.00 | 8,324.0000 | 0 | 12.47% | 0.00% |
| Jan. 23, 2024 | Jones Christopher Ian Montague | Director | A | Common Stock | 900 | $0.00 | 21,405.0000 | 288,392,000 | 4.39% | 0.00% |
| Jan. 23, 2024 | RING TIMOTHY M | Director | A | Common Stock | 900 | $0.00 | 59,082.0000 | 288,392,000 | 1.55% | 0.00% |
| Jan. 23, 2024 | Brown William M | Director | A | Common Stock | 900 | $0.00 | 2,512.0000 | 288,392,000 | 55.83% | 0.00% |
| Jan. 23, 2024 | Byington Carrie L | Director | A | Common Stock | 900 | $0.00 | 2,855.0000 | 288,392,000 | 46.04% | 0.00% |
| Jan. 23, 2024 | ECKERT R ANDREW | Director | A | Common Stock | 900 | $0.00 | 8,124.0000 | 288,392,000 | 12.46% | 0.00% |
| Jan. 23, 2024 | Fraser Claire | Director | A | Common Stock | 900 | $0.00 | 22,696.0000 | 288,392,000 | 4.13% | 0.00% |
| Jan. 23, 2024 | Henderson Jeffrey William | Director | A | Common Stock | 900 | $0.00 | 5,583.0000 | 288,392,000 | 19.22% | 0.00% |
| Jan. 23, 2024 | Waldstreicher Joanne | Director | A | Common Stock | 900 | $0.00 | 1,323.0000 | 288,392,000 | 212.77% | 0.00% |
| Jan. 23, 2024 | SCOTT BERTRAM L | Director | A | Common Stock | 900 | $0.00 | 35,197.0000 | 288,392,000 | 2.62% | 0.00% |
| Jan. 23, 2024 | BURZIK CATHERINE M | Director | A | Common Stock | 900 | $0.00 | 13,242.0000 | 288,392,000 | 7.29% | 0.00% |
| Nov. 16, 2023 | Goette Roland | EVP and President, EMEA | D | Common Stock | 2233 | $235.07 | 14,931.0000 | 288,392,000 | 13.01% | 0.00% |
| Jan. 3, 2024 | Shan David | EVP and Chief ISC Officer | F | Common Stock | 44 | $0.00 | 5,693.0000 | 288,392,000 | 0.77% | 0.00% |
| Jan. 24, 2023 | Jones Christopher Ian Montague | Director | A | Common Stock | 848 | $0.00 | 20,198.0000 | 0 | 4.38% | 0.00% |
| Dec. 11, 2023 | Garrison Michael David | EVP & President Medical | S | Common Stock | 1239 | $232.46 | 7,274.0000 | 288,392,000 | 14.55% | 0.00% |
| Nov. 28, 2023 | Byrd Richard | EVP & President Interventional | S | Common Stock | 2156 | $238.47 | 4,120.0000 | 288,392,000 | 34.35% | 0.00% |
| Nov. 26, 2023 | Goette Roland | EVP and President EMEA | A | Stock Appreciation Rights | 3225 | $0.00 | 3,225.0000 | 288,392,000 | 9999.99% | 0.00% |
| Nov. 26, 2023 | Spoerel Thomas J | SVPController & Chief Acct Off | A | Common Stock | 375 | $0.00 | 2,304.0000 | 288,392,000 | 19.44% | 0.00% |
| Nov. 26, 2023 | Spoerel Thomas J | SVPController & Chief Acct Off | A | Common Stock | 757 | $0.00 | 3,061.0000 | 288,392,000 | 32.86% | 0.00% |
| Nov. 26, 2023 | Spoerel Thomas J | SVPController & Chief Acct Off | F | Common Stock | 365 | $0.00 | 2,696.0000 | 288,392,000 | 11.92% | 0.00% |
| Nov. 26, 2023 | Spoerel Thomas J | SVPController & Chief Acct Off | A | Stock Appreciation Rights | 2764 | $0.00 | 2,674.0000 | 288,392,000 | 0.00% | 0.00% |
| Nov. 26, 2023 | Hickey David | EVP & President, Life Sciences | A | Common Stock | 1663 | $0.00 | 5,862.0000 | 288,392,000 | 39.60% | 0.00% |
| Nov. 26, 2023 | Hickey David | EVP & President, Life Sciences | A | Stock Appreciation Rights | 9213 | $0.00 | 9,213.0000 | 288,392,000 | 9999.99% | 0.00% |
| Nov. 26, 2023 | Hickey David | EVP & President, Life Sciences | A | Rights to Common Stock Under Deferred Compensation Plan | 3024 | $0.00 | 12,237.0000 | 288,392,000 | 32.82% | 0.00% |
| Nov. 26, 2023 | Byrd Richard | EVP & President Interventional | A | Common Stock | 1455 | $0.00 | 4,899.0000 | 288,392,000 | 42.25% | 0.00% |
| Nov. 26, 2023 | Byrd Richard | EVP & President Interventional | A | Common Stock | 2886 | $0.00 | 7,785.0000 | 288,392,000 | 58.91% | 0.00% |
| Nov. 26, 2023 | Byrd Richard | EVP & President Interventional | F | Common Stock | 1509 | $0.00 | 6,276.0000 | 288,392,000 | 19.38% | 0.00% |
| Nov. 26, 2023 | Byrd Richard | EVP & President Interventional | A | Stock Appreciation Rights | 8061 | $0.00 | 8,061.0000 | 288,392,000 | 9999.99% | 0.00% |
| Nov. 26, 2023 | DelOrefice Christopher | EVP & Chief Financial Officer | A | Common Stock | 3325 | $0.00 | 14,324.0000 | 288,392,000 | 30.23% | 0.00% |
| Nov. 26, 2023 | DelOrefice Christopher | EVP & Chief Financial Officer | F | Common Stock | 812 | $0.00 | 13,512.0000 | 288,392,000 | 5.67% | 0.00% |
| Nov. 26, 2023 | DelOrefice Christopher | EVP & Chief Financial Officer | A | Stock Appreciation Rights | 18425 | $0.00 | 18,425.0000 | 288,392,000 | 9999.99% | 0.01% |
| Nov. 26, 2023 | Garrison Michael David | EVP & President Medical | A | Common Stock | 1871 | $0.00 | 7,028.0000 | 288,392,000 | 36.28% | 0.00% |
| Nov. 26, 2023 | Garrison Michael David | EVP & President Medical | A | Common Stock | 3131 | $0.00 | 10,159.0000 | 288,392,000 | 44.55% | 0.00% |
| Nov. 26, 2023 | Garrison Michael David | EVP & President Medical | F | Common Stock | 1646 | $0.00 | 8,513.0000 | 288,392,000 | 16.20% | 0.00% |
| Nov. 26, 2023 | Garrison Michael David | EVP & President Medical | A | Stock Appreciation Rights | 10364 | $0.00 | 10,364.0000 | 288,392,000 | 9999.99% | 0.00% |
| Nov. 26, 2023 | Mocherla Pavan Kumar | EVP & President Greater Asia | A | Common Stock | 499 | $0.00 | 1,629.0000 | 288,392,000 | 44.16% | 0.00% |
| Nov. 26, 2023 | Mocherla Pavan Kumar | EVP & President Greater Asia | A | Common Stock | 252 | $0.00 | 1,881.0000 | 288,392,000 | 15.47% | 0.00% |
| Nov. 26, 2023 | Mocherla Pavan Kumar | EVP & President Greater Asia | F | Common Stock | 64 | $0.00 | 1,817.0000 | 288,392,000 | 3.40% | 0.00% |
| Nov. 26, 2023 | Mocherla Pavan Kumar | EVP & President Greater Asia | A | Stock Appreciation Rights | 2764 | $0.00 | 2,764.0000 | 288,392,000 | 9999.99% | 0.00% |
| Nov. 26, 2023 | Neal Shana Carol | EVP and Chief People Officer | A | Common Stock | 1659 | $0.00 | 18,568.0000 | 288,392,000 | 9.81% | 0.00% |
| Nov. 26, 2023 | Neal Shana Carol | EVP and Chief People Officer | F | Common Stock | 258 | $0.00 | 18,310.0000 | 288,392,000 | 1.39% | 0.00% |
| Nov. 26, 2023 | Neal Shana Carol | EVP and Chief People Officer | A | Stock Appreciation Rights | 9190 | $0.00 | 9,190.0000 | 288,392,000 | 9999.99% | 0.00% |
| Nov. 26, 2023 | Quinn Michelle | EVP and General Counsel | A | Common Stock | 1206 | $0.00 | 4,486.0000 | 288,392,000 | 36.77% | 0.00% |
| Nov. 26, 2023 | Quinn Michelle | EVP and General Counsel | A | Common Stock | 909 | $0.00 | 5,395.0000 | 288,392,000 | 20.26% | 0.00% |
| Nov. 26, 2023 | Quinn Michelle | EVP and General Counsel | F | Common Stock | 440 | $0.00 | 4,955.0000 | 288,392,000 | 8.16% | 0.00% |
| Nov. 26, 2023 | Quinn Michelle | EVP and General Counsel | A | Stock Appreciation Rights | 6679 | $0.00 | 6,679.0000 | 288,392,000 | 9999.99% | 0.00% |
| Nov. 26, 2023 | Shan David | EVP and Chief ISC Officer | A | Common Stock | 832 | $0.00 | 4,310.0000 | 288,392,000 | 23.92% | 0.00% |
| Nov. 26, 2023 | Shan David | EVP and Chief ISC Officer | A | Common Stock | 1576 | $0.00 | 5,886.0000 | 288,392,000 | 36.57% | 0.00% |
| Nov. 26, 2023 | Shan David | EVP and Chief ISC Officer | F | Common Stock | 149 | $0.00 | 5,737.0000 | 288,392,000 | 2.53% | 0.00% |
| Nov. 26, 2023 | Shan David | EVP and Chief ISC Officer | A | Stock Appreciation Rights | 4607 | $0.00 | 4,607.0000 | 288,392,000 | 9999.99% | 0.00% |
| Nov. 26, 2022 | Polen Thomas E Jr | Chairman, CEO and President | A | Common Stock | 11429 | $0.00 | 59,089.0000 | 0 | 23.98% | 0.00% |
| Nov. 26, 2022 | Polen Thomas E Jr | Chairman, CEO and President | A | Common Stock | 32296 | $0.00 | 91,385.0000 | 0 | 54.66% | 0.00% |
| Nov. 26, 2022 | Polen Thomas E Jr | Chairman, CEO and President | F | Common Stock | 19574 | $0.00 | 71,811.0000 | 0 | 21.42% | 0.00% |
| Nov. 26, 2023 | Polen Thomas E Jr | Chairman, CEO and President | A | Stock Appreciation Rights | 63335 | $0.00 | 63,335.0000 | 288,392,000 | 9999.99% | 0.02% |
| Nov. 26, 2023 | Polen Thomas E Jr | Chairman, CEO and President | A | Rights to Common Stock Under Deferred Compensation Plan | 7520 | $0.00 | 70,855.0000 | 288,392,000 | 11.87% | 0.00% |
| Nov. 26, 2023 | Ezell Antoine C | EVP, President NA & CMO | A | Common Stock | 956 | $0.00 | 8,143.0000 | 288,392,000 | 13.30% | 0.00% |
| Nov. 26, 2023 | Ezell Antoine C | EVP, President NA & CMO | A | Common Stock | 3113 | $0.00 | 11,256.0000 | 288,392,000 | 38.23% | 0.00% |
| Nov. 26, 2023 | Ezell Antoine C | EVP, President NA & CMO | F | Common Stock | 1654 | $0.00 | 9,602.0000 | 288,392,000 | 14.69% | 0.00% |
| Nov. 26, 2023 | Ezell Antoine C | EVP, President NA & CMO | A | Stock Appreciation Rights | 5298 | $0.00 | 5,298.0000 | 288,392,000 | 9999.99% | 0.00% |
| Nov. 26, 2023 | Goette Roland | EVP and President EMEA | A | Common Stock | 582 | $0.00 | 17,072.0000 | 288,392,000 | 3.53% | 0.00% |
| Nov. 26, 2023 | Goette Roland | EVP and President EMEA | A | Common Stock | 2608 | $0.00 | 19,680.0000 | 288,392,000 | 15.28% | 0.00% |
| Nov. 26, 2023 | Goette Roland | EVP and President EMEA | F | Common Stock | 213 | $0.00 | 19,467.0000 | 288,392,000 | 1.08% | 0.00% |
| Nov. 16, 2023 | Goette Roland | EVP and President, EMEA | M | Common Stock | 3544 | $107.12 | 18,241.0000 | 288,392,000 | 24.11% | 0.00% |
| Nov. 16, 2023 | Goette Roland | EVP and President, EMEA | M | Stock Appreciation Rights | 3544 | $0.00 | 0.0000 | 288,392,000 | 100.00% | 0.00% |
| Nov. 16, 2023 | Goette Roland | EVP and President, EMEA | D | Common Stock | 1751 | $235.07 | 16,490.0000 | 288,392,000 | 9.60% | 0.00% |
| Nov. 3, 2023 | Byington Carrie L | Director | A | Rights to Common Stock Under BD Deferred Compensation Plan | 118 | $252.78 | 910.0000 | 288,392,000 | 14.90% | 0.00% |
| Nov. 3, 2023 | Jones Christopher Ian Montague | Director | A | Rights to Common Stock Under BD Deferred Compensation Plan | 118 | $252.78 | 9,624.0000 | 288,392,000 | 1.24% | 0.00% |
| Sept. 7, 2023 | DelOrefice Christopher | EVP & Chief Financial Officer | F | Common Stock | 601 | $0.00 | 10,999.0000 | 0 | 5.18% | 0.00% |
| Sept. 5, 2023 | Byrd Richard | EVP & President Interventional | S | Common Stock | 459 | $274.48 | 3,444.0000 | 0 | 11.76% | 0.00% |
| Sept. 1, 2023 | DelOrefice Christopher | EVP & Chief Financial Officer | F | Common Stock | 353 | $0.00 | 11,600.0000 | 0 | 2.95% | 0.00% |
| Sept. 1, 2023 | Byrd Richard | EVP & President Interventional | F | Common Stock | 216 | $0.00 | 3,903.0000 | 0 | 5.24% | 0.00% |
| Aug. 28, 2023 | Fraser Claire | Director | S | Common Stock | 848 | $281.66 | 21,608.0000 | 0 | 3.78% | 0.00% |
| Aug. 11, 2023 | Hickey David | EVP & President, Life Sciences | M | Stock Appreciation Rights | 3883 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Aug. 11, 2023 | Hickey David | EVP & President, Life Sciences | M | Common Stock | 3883 | $132.54 | 9,030.0000 | 0 | 75.44% | 0.00% |
| Aug. 11, 2023 | Hickey David | EVP & President, Life Sciences | D | Common Stock | 1857 | $277.85 | 7,173.0000 | 0 | 20.56% | 0.00% |
| Aug. 11, 2023 | Hickey David | EVP & President, Life Sciences | S | Common Stock | 2974 | $277.85 | 4,199.0000 | 0 | 41.46% | 0.00% |
| Aug. 8, 2023 | Garrison Michael David | EVP & President Medical | S | Common Stock | 1300 | $277.13 | 5,157.0000 | 0 | 20.13% | 0.00% |
| Aug. 2, 2023 | Jones Christopher Ian Montague | Director | A | Rights to Common Stock Under BD Deferred Compensation Plan | 108 | $276.23 | 9,441.0000 | 0 | 1.16% | 0.00% |
| Aug. 2, 2023 | Byington Carrie L | Director | A | Rights to Common Stock Under BD Deferred Compensation Plan | 108 | $276.24 | 785.0000 | 0 | 15.95% | 0.00% |
| July 24, 2023 | Waldstreicher Joanne | Director | A | Common Stock | 419 | $0.00 | 419.0000 | 0 | 9999.99% | 0.00% |
| July 1, 2023 | Spoerel Thomas J | VP Controller & Chief Acct Off | A | Common Stock | 47 | $0.00 | 1,928.0000 | 0 | 2.38% | 0.00% |
| May 5, 2023 | Jones Christopher Ian Montague | Director | A | Rights to Common Stock Under BD Deferred Compensation Plan | 118 | $253.66 | 9,270.0000 | 0 | 1.29% | 0.00% |
| May 5, 2023 | Byington Carrie L | Director | A | Rights to Common Stock Under BD Deferred Compensation Plan | 118 | $253.66 | 671.0000 | 0 | 21.34% | 0.00% |
| May 1, 2023 | Quinn Michelle | EVP and General Counsel | F | Common Stock | 99 | $0.00 | 3,280.0000 | 0 | 2.93% | 0.00% |
| April 4, 2023 | Neal Shana Carol | Chief Human Resources Officer | F | Common Stock | 731 | $0.00 | 8,680.0000 | 0 | 7.77% | 0.00% |
| April 4, 2023 | Neal Shana Carol | Chief Human Resources Officer | A | Common Stock | 8229 | $0.00 | 16,909.0000 | 0 | 94.80% | 0.00% |
| March 2, 2023 | Ezell Antoine C | EVP, President NA & CMO | F | Common Stock | 650 | $0.00 | 7,187.0000 | 0 | 8.29% | 0.00% |
| March 1, 2023 | Ezell Antoine C | EVP, President NA & CMO | F | Common Stock | 418 | $0.00 | 7,837.0000 | 0 | 5.06% | 0.00% |
| March 1, 2023 | Spoerel Thomas J | SVP,Controller&Chief Acct Off | F | Common Stock | 35 | $0.00 | 1,971.0000 | 0 | 1.74% | 0.00% |
| March 1, 2023 | Garrison Michael David | EVP & President Medical | F | Common Stock | 193 | $0.00 | 6,457.0000 | 0 | 2.90% | 0.00% |
| Feb. 3, 2023 | Byrd Richard | EVP & President Interventional | S | Common Stock | 1421 | $248.60 | 4,119.0000 | 0 | 25.65% | 0.00% |
| Feb. 2, 2023 | Jones Christopher Ian Montague | Director | A | Rights to Common Stock Under BD Deferred Compensation Plan | 205 | $252.22 | 9,086.0000 | 0 | 2.31% | 0.00% |
| Feb. 2, 2023 | Byington Carrie L | Director | A | Rights to Common Stock Under BD Deferred Compensation Plan | 106 | $252.22 | 548.0000 | 0 | 23.98% | 0.00% |
| Jan. 24, 2023 | Jones Christopher Ian Montague | Director | A | Common Stock | 848 | $0.00 | 29,171.0000 | 0 | 2.99% | 0.00% |
| Jan. 24, 2023 | SCOTT BERTRAM L | Director | A | Common Stock | 848 | $0.00 | 33,779.0000 | 0 | 2.58% | 0.00% |
| Jan. 24, 2023 | RING TIMOTHY M | Director | A | Common Stock | 848 | $0.00 | 81,221.0000 | 0 | 1.06% | 0.00% |
| Jan. 24, 2023 | LARSEN MARSHALL O | Director | A | Common Stock | 848 | $0.00 | 28,919.0000 | 0 | 3.02% | 0.00% |
| Jan. 24, 2023 | Henderson Jeffrey William | Director | A | Common Stock | 848 | $0.00 | 4,653.0000 | 0 | 22.29% | 0.00% |
| Jan. 26, 2023 | Fraser Claire | Director | A | Common Stock | 848 | $0.00 | 22,311.0000 | 0 | 3.95% | 0.00% |
| Jan. 24, 2023 | ECKERT R ANDREW | Director | A | Common Stock | 848 | $0.00 | 6,992.0000 | 0 | 13.80% | 0.00% |
| Jan. 24, 2023 | BURZIK CATHERINE M | Director | A | Common Stock | 848 | $0.00 | 13,425.0000 | 0 | 6.74% | 0.00% |
| Jan. 24, 2023 | Byington Carrie L | Director | A | Common Stock | 848 | $0.00 | 1,924.0000 | 0 | 78.81% | 0.00% |
| Jan. 24, 2023 | Brown William M | Director | A | Common Stock | 848 | $0.00 | 1,586.0000 | 0 | 114.91% | 0.00% |
| Dec. 21, 2022 | Khichi Samrat S. | EVP and General Counsel | G | Common Stock | 19 | $0.00 | 9,251.0000 | 0 | 0.20% | 0.00% |